
"Your body is the most complex machine you own, but it didn’t come with instructions. I'm writing the Owner's Manual."
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 1500 | Founded | 6 years ago | Last Issue | 5 days ago |
| Active | |||||

In Part 1 of this series, we exposed how a cellular “switch” called Asymmetrical Dimethylarginine (ADMA)—essential for fetal development—turns destructive when reactivated in adult life, driving silent vascular disease and skyrocketing heal...
Every year, your health plan spends millions of dollars managing the severe, costly downstream complications of chronic disease—heart attacks, strokes, advanced chronic kidney disease (CKD), and metabolic decline.
Traditional healthcare be...
You may have noticed an early draft of our new series introduction land in your inbox on Sunday before I took it down to finalize the text.
The complete, updated version is now live:
👉
Introduction: The Disruptive New Science of Chronic...
In our previous posts, we established three critical truths:
Metformin does not injure the kidneys; it is cleared by them and remains safe to use down to an eGFR of 30. (about one third of normal kidney function)
As kidney filtr...
To the Chief Medical Officer, Chief Human Resources Officer, Benefits Director, Family Decision-Maker, and Engaged Employee:
The new science of chronic disease is moving forward at a blistering pace. The opportunity to be healthier longer...
Subscribers, engagement, traffic and sponsorship for Slow Aging and Delay Chronic Disease Development.
| Subscribers | Engagement | 81 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Dr. Bill Bestermann is an internal medicine doctor who practiced preventive cardiology for the last 20 years of his practice. He has learned that certain medicines have a more positive effect on your health than others and explains why.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.